secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2024-03-19T23:59:59+00:00
Accession:  0001628280-24-011930
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead shareholders elect 7 directors, approve exec pay, ratify KPMG at 2024 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected; votes for ranged from 76.4M (Given) to 84.3M (Anzalone), with ~19.3M broker non-votes.
- Advisory vote on executive compensation passed with 82.6M for, 4.95M against, 143k abstain.
- Ratification of KPMG as independent auditor for FY2024 passed with 104.1M for, 2.6M against, 366k abstain.
- Record date Jan 19, 2024; 106.99M of 123.84M shares voted at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/0001628280-24-011930-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/arwr-20240314.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-011930

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer